(Q50533661)

English

Neurotrophin 3 genotype and emotional adverse effects of osmotic-release oral system methylphenidate (OROS-MPH) in children with attention-deficit/hyperactivity disorder.

scientific article published on 7 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

Neurotrophin 3 genotype and emotional adverse effects of osmotic-release oral system methylphenidate (OROS-MPH) in children with attention-deficit/hyperactivity disorder. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

attention deficit hyperactivity disorder

1 reference

based on heuristic

inferred from title

9

object named as

Un-Sun Chung

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

2

object named as

Bung-Nyun Kim

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

5

object named as

Soo-Churl Cho

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

4

object named as

Min-Sup Shin

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

1

object named as

Subin Park

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

10

object named as

Doug-Hyun Han

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

author name string

Jae-Won Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

Ji-Hoon Kim

6

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

Jung-Woo Son

7

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

Yun-Mi Shin

8

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

language of work or name

0 references

publication date

7 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

28

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

220-226

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

Neurotrophins and depression

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Gender-specific association of the brain-derived neurotrophic factor gene with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Neurotrophic factor-related gene polymorphisms and adult attention deficit hyperactivity disorder (ADHD) score in a high-risk male population

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Dose-response variation among different populations

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Synaptic plasticity and mood disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Genome-wide association studies in ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Mutant mice reveal the molecular and cellular basis for specific sensory connections to inner ear epithelia and primary nuclei of the brain

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

An open-label, randomized, active-controlled equivalent trial of osmotic release oral system methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Increased cerebrospinal fluid levels of neurotrophin 3 (NT-3) in elderly patients with major depression.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Neurotrophins: roles in neuronal development and function

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean version (K-SADS-PL-K).

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

The neurotrophins and their receptors: structure, function, and neuropathology

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

The worldwide prevalence of ADHD: a systematic review and metaregression analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and somatic complaint side effects

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Unexpected effects of methylphenidate in attention-deficit/hyperactivity disorder reflect decreases in core/secondary symptoms and physical complaints common to all children.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

SNPStats: a web tool for the analysis of association studies.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Adverse reactions to methylphenidate treatment for attention-deficit/hyperactivity disorder: structure and associations with clinical characteristics and symptom control

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Dopamine transporter genotype and methylphenidate dose response in children with ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

An investigation of the neurotrophic factor genes GDNF, NGF, and NT3 in susceptibility to ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Safety and tolerability of methylphenidate in preschool children with ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Family-based association study between brain-derived neurotrophic factor gene polymorphisms and attention deficit hyperactivity disorder in UK and Taiwanese samples.

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes

1 reference

https://api.crossref.org/works/10.1177%2F0269881113480989

21 January 2018

Identifiers

10.1177/0269881113480989

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/23471121

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50533661&oldid=2126795999"